• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

Mesa Biotech Inc.

Mesa Biotech has developed and commercialized a PCR-based rapid point-of-care testing platform available for detecting infectious diseases including SARS-CoV-2, Influenza A and B, respiratory syncytial virus (RSV) and Strep A. Mesa Biotech's patented technology expands the availability of gold standard nucleic acid PCR amplification to point-of-care diagnostics. The company is based in San Diego, California and has approximately 500 employees and revenues in 2020 of approximately $45 million. Mesa Biotech's Accula™ Flu A/Flu B, RSV and Strep A tests have obtained 510(k) clearance and Clinical Laboratory Improvements Amendments (CLIA) waivers from the U.S. Food and Drug Administration (FDA). Additionally, the Accula System has received Emergency Use Authorization (EUA) from the FDA for SARS-CoV-2 in vitro diagnostic testing and is now available for use in patient care settings, providing results within 30 minutes, with higher accuracy than other rapid tests on the market. *

 

	Start	2021-01-19 existent
	Group	Thermo Fisher (Group)
	Industry	molecular diagnostics
	Industry 2	PCR test (clinical diagnostics)
	Person	Chakravarty, Ingo (Mesa Biotech 202101 CEO)
	Region	San Diego, CA
	Country	United States (USA)
	City	n. a. San Diego, CA
		Address record changed: 2021-01-19
Basic data	Employees	D: 101 to 500 (2021-01-19)
	Currency	USD
	Annual sales	45,000,000 (sales, annual (2020) 2020-12-31)
		* Document for �About Section�: Thermo Fisher Scientific Inc.. (1/19/21). "Press Release: Thermo Fisher Scientific to Acquire Point-of-Care Molecular Diagnostics Provider Mesa Biotech". Waltham, MA.
		Record changed: 2021-01-19

Advertisement

More documents for Thermo Fisher (Group)

• [1] Thermo Fisher Scientific Inc.. (2/17/21). "Press Release: Thermo Fisher Scientific Acquires Leading Cell Sorting Technology from Propel Labs". Waltham, MA....
• [2] Thermo Fisher Scientific Inc.. (1/19/21). "Press Release: Thermo Fisher Scientific to Acquire Point-of-Care Molecular Diagnostics Provider Mesa Biotech". Waltham, MA....
• [3] Thermo Fisher Scientific Inc.. (1/15/21). "Press Release: Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep". Waltham, MA & Lyon....
• [4] Thermo Fisher Scientific Inc.. (12/31/20). "Press Release: Thermo Fisher Scientific Acquires Programmable Dye Platform Pioneer Phitonex". Waltham, MA....
• [5] Protein Metrics Inc.. (11/23/20). "Press Release: Kevin Cronin Joins Protein Metrics as Vice President of Corporate Development". Cupertino, CA....
• [6] Thermo Fisher Scientific Inc.. (8/4/20). "Press Release: Thermo Fisher Scientific Confirms Offer to Acquire Qiagen Shares Expires on August 10". Waltham, MA....
• [7] Qiagen N.V.. (7/16/20). "Press Release: Thermo Fisher Scientific and Qiagen N.V. Agree on Amended Terms to Acquisition Agreement". Waltham, MA & Venlo....
• [8] Intabio, Inc.. (6/16/20). "Press Release: Intabio Launches Blaze System to Accelerate Biotherapeutic Development". Newark, CA....
• [9] Qiagen N.V.. (3/24/20). "Press Release: Qiagen Names Thierry Bernard as Chief Executive Officer". Venlo, Hilden & Germantown, MD....
• [10] Thermo Fisher Scientific Inc.. (3/10/20). "Press Release: Thermo Fisher Scientific Names Paul G. Parker to Head Strategy and Corporate Development". Waltham, MA....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.